» Articles » PMID: 20171613

Prospective Randomized Comparison of Human Oocyte Cryopreservation with Slow-rate Freezing or Vitrification

Overview
Journal Fertil Steril
Date 2010 Feb 23
PMID 20171613
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To compare cryopreservation of mature human oocytes with slow-rate freezing and vitrification and determine which is most efficient at establishing a pregnancy.

Design: Prospective randomized.

Setting: Academically affiliated, private fertility center.

Patient(s): Consenting patients with concerns about embryo cryopreservation and more than nine mature oocytes at retrieval were randomized to slow-rate freezing or vitrification of supernumerary (more than nine) oocytes.

Intervention(s): Oocytes were frozen or vitrified, and upon request oocytes were thawed or warmed, respectively.

Main Outcome Measure(s): Oocyte survival, fertilization, embryo development, and clinical pregnancy.

Result(s): Patient use has resulted in 30 thaws and 48 warmings. Women's age at time of cryopreservation was similar. Oocyte survival was significantly higher following vitrification/warming (81%) compared with freezing/thawing (67%). Fertilization was more successful in oocytes vitrified/warmed compared with frozen/thawed. Fertilized oocytes from vitrification/warming had significantly better cleavage rates (84%) compared with freezing/thawing (71%) and resulted in embryos with significantly better morphology. Although similar numbers of embryos were transferred, embryos resulting from vitrified oocytes had significantly enhanced clinical (38%) pregnancy rates compared with embryos resulting from frozen oocyte (13%). Miscarriage and/or spontaneous abortion rates were similar.

Conclusion(s): Our results suggest that vitrification/warming is currently the most efficient means of oocyte cryopreservation in relation to subsequent success in establishing pregnancy.

Citing Articles

Cryopreservation, cryoprotectants, and potential risk of epigenetic alteration.

Sciorio R, Cantatore C, DAmato G, Smith G J Assist Reprod Genet. 2024; 41(11):2953-2967.

PMID: 39436484 PMC: 11621268. DOI: 10.1007/s10815-024-03287-3.


Oocytes Vitrification Using Automated Equipment Based on Microfluidic Chip.

Shen J, Yu Z, Li W, Zhou X Ann Biomed Eng. 2024; 53(2):471-480.

PMID: 39320573 DOI: 10.1007/s10439-024-03623-9.


Blastocyst formation in vitrified-warmed preimplantation embryos derived from vitrified-warmed oocytes in a mouse model.

Hong Y, Jee B Clin Exp Reprod Med. 2024; 51(1):57-62.

PMID: 38433015 PMC: 10914501. DOI: 10.5653/cerm.2023.06499.


The role of Hippo pathway in ovarian development.

Zhu M, Xu M, Zhang J, Zheng C Front Physiol. 2023; 14:1198873.

PMID: 37334049 PMC: 10275494. DOI: 10.3389/fphys.2023.1198873.


Impacts of vitrification on the transcriptome of human ovarian tissue in patients with gynecological cancer.

Gu R, Ge N, Huang B, Fu J, Zhang Y, Wang N Front Genet. 2023; 14:1114650.

PMID: 37007967 PMC: 10063885. DOI: 10.3389/fgene.2023.1114650.